{"protocolSection": {"identificationModule": {"nctId": "NCT01280409", "orgStudyIdInfo": {"id": "HSC-MS-10-0426"}, "organization": {"fullName": "The University of Texas Health Science Center, Houston", "class": "OTHER"}, "briefTitle": "Metformin Postpartum for GDM RCT for Reduced Weight Retention", "officialTitle": "The Effects of Metformin on Retained Postpartum Weight in Women With Gestational Diabetes: A Randomized, Placebo-Controlled Trial"}, "statusModule": {"statusVerifiedDate": "2018-11", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-01"}, "primaryCompletionDateStruct": {"date": "2014-03", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-08", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-01-19", "studyFirstSubmitQcDate": "2011-01-19", "studyFirstPostDateStruct": {"date": "2011-01-20", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2016-02-29", "resultsFirstSubmitQcDate": "2018-11-01", "resultsFirstPostDateStruct": {"date": "2018-11-28", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-11-01", "lastUpdatePostDateStruct": {"date": "2018-11-28", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Jerrie Refuerzo", "investigatorTitle": "Associate Professor", "investigatorAffiliation": "The University of Texas Health Science Center, Houston"}, "leadSponsor": {"name": "The University of Texas Health Science Center, Houston", "class": "OTHER"}, "collaborators": [{"name": "Gilstrap, Larry C, M.D.", "class": "INDIV"}]}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of this study is to determine whether the study drug metformin is helpful in reducing weight after pregnancy in women with gestational diabetes. This pilot study will provide information on how well women are able to take metformin postpartum, whether metformin increases weight loss, and whether there are any increased risks of side effects to you as a new mother.", "detailedDescription": "At 24-48 hours after delivery, women who are eligible for participation will be approached and consented to the study. Maternal weight will be measured and 20ml of maternal blood will be obtained to assess glucose control and lipid profile. Women will be counseled regarding diet, exercise and glucose control. Data including maternal demographics, clinical characteristics and neonatal outcomes will be collected. At 3 weeks postpartum, a research nurse will contact the subject via telephone call to inquire about adverse or side effects, ability to take the prescribed medication (metformin or placebo), and to answer questions about the study. At 6 weeks postpartum, maternal weight will be measured , blood will be obtained and side effects will be evaluated again. Finally, a satisfaction survey will be completed."}, "conditionsModule": {"conditions": ["Diabetes, Gestational"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 114, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "Compounded placebo", "interventionNames": ["Drug: Placebo"]}, {"label": "Metformin", "type": "EXPERIMENTAL", "description": "Compounded metformin as the intervention", "interventionNames": ["Drug: Metformin"]}], "interventions": [{"type": "DRUG", "name": "Metformin", "description": "Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks", "armGroupLabels": ["Metformin"]}, {"type": "DRUG", "name": "Placebo", "description": "Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks.", "armGroupLabels": ["Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Weight Change", "description": "The weight change in kilograms defined as:\n\nweight change = Weight(pp) - Weight(6wk)", "timeFrame": "within 24 hours after delivery; at 6 weeks postpartum visit (2nd research visit)"}], "secondaryOutcomes": [{"measure": "Number of Participants Who Achieved Pre-pregnancy Weight", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Number of Participants Who Achieved Their Ideal Body Weight", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Hemoglobin a1c", "description": "We will calculate the change in hemoglobin a1c.", "timeFrame": "At 6 weeks postpartum"}, {"measure": "HDL, LDL, Triglyceride", "description": "We will calculate the change in LDL, HDL, and triglyceride levels.", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Self-reported Compliance With Medications", "timeFrame": "3 weeks postpartum"}, {"measure": "Self-reported Compliance With Medications", "timeFrame": "6 weeks postpartum"}, {"measure": "Difficulty With Diet as Assessed by a 5-point Likert Scale", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Difficulty With Exercise as Assessed by a 5-point Likert Scale", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Difficulty With Medication as Assessed by a 5-point Likert Scale", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Satisfaction With Diet as Assessed by a 5-point Likert Scale", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Satisfaction With Exercise as Assessed by a 5-point Likert Scale", "timeFrame": "At 6 weeks postpartum"}, {"measure": "Satisfaction With Medication as Assessed by a 5-point Likert Scale", "timeFrame": "At 6 weeks postpartum"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Postpartum women with a delivery greater than 34 weeks of pregnancy\n* Between the ages of 18 to 49 years\n* Women with a diagnosis of gestational diabetes mellitus (either treated with insulin, oral hypoglycemic agent or diet-controlled) after 24 weeks in most recent pregnancy based on a confirmatory 3 hour glucola test (based on either the Carpenter and Coustan's of the Diabetes Task Force criteria)\n\nExclusion Criteria:\n\n* women with pre-gestational diabetes mellitus (either Type I or Type II DM)\n* women unable to tolerate metformin based on patient history\n* women who will be discharged hom eon insulin or oral hypoglycemic agent in the immediate postpartum period\n* women with a BMI \\<25 kg/m\u00b2", "healthyVolunteers": false, "sex": "FEMALE", "minimumAge": "18 Years", "maximumAge": "49 Years", "stdAges": ["ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Jerrie S Refuerzo, MD", "affiliation": "The University of Texas Health Science Center, Houston", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Memorial Hermann Hospital, Texas Medical Center", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "University of Texas Health Science Center at Houston, Professional Building", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "FG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "59"}, {"groupId": "FG001", "numSubjects": "55"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "43"}, {"groupId": "FG001", "numSubjects": "36"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "16"}, {"groupId": "FG001", "numSubjects": "19"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "BG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "79"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "79"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "28.8", "spread": "6.4"}, {"groupId": "BG001", "value": "31.6", "spread": "5.3"}, {"groupId": "BG002", "value": "30.2", "spread": "5.8"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "79"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "79"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Weight Change", "description": "The weight change in kilograms defined as:\n\nweight change = Weight(pp) - Weight(6wk)", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "kg", "timeFrame": "within 24 hours after delivery; at 6 weeks postpartum visit (2nd research visit)", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.5", "lowerLimit": "-0.3", "upperLimit": "12.1"}, {"groupId": "OG001", "value": "6.3", "lowerLimit": "-0.3", "upperLimit": "19.8"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Who Achieved Pre-pregnancy Weight", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "15"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Who Achieved Their Ideal Body Weight", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Hemoglobin a1c", "description": "We will calculate the change in hemoglobin a1c.", "populationDescription": "This data is not reported because blood samples were not analyzed for Hemoglobin a1c.", "reportingStatus": "POSTED", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "HDL, LDL, Triglyceride", "description": "We will calculate the change in LDL, HDL, and triglyceride levels.", "populationDescription": "This data is not reported because blood samples were not analyzed for HDL, LDL, and triglyceride.", "reportingStatus": "POSTED", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Self-reported Compliance With Medications", "populationDescription": "46 in the placebo group and 53 in the metformin group were available by phone at 3 weeks postpartum to indicate medication compliance.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "46"}, {"groupId": "OG001", "value": "53"}]}], "classes": [{"categories": [{"title": "Unknown", "measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "4"}]}, {"title": "less than 50%", "measurements": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "10"}]}, {"title": "greater than 50%", "measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "20"}]}, {"title": "100%", "measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "19"}]}]}]}, {"type": "SECONDARY", "title": "Self-reported Compliance With Medications", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"title": "Unknown", "measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}, {"title": "less than 50%", "measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}, {"title": "greater than 50%", "measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "18"}]}, {"title": "100%", "measurements": [{"groupId": "OG000", "value": "28"}, {"groupId": "OG001", "value": "17"}]}]}]}, {"type": "SECONDARY", "title": "Difficulty With Diet as Assessed by a 5-point Likert Scale", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"title": "Not at all", "measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "9"}]}, {"title": "Slightly", "measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "10"}]}, {"title": "Moderately", "measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}, {"title": "Quite", "measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "1"}]}, {"title": "Extremely", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "2"}]}]}]}, {"type": "SECONDARY", "title": "Difficulty With Exercise as Assessed by a 5-point Likert Scale", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"title": "Not at all", "measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "11"}]}, {"title": "Slightly", "measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "6"}]}, {"title": "Moderately", "measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "13"}]}, {"title": "Quite", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "5"}]}, {"title": "Extremely", "measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Difficulty With Medication as Assessed by a 5-point Likert Scale", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"title": "Not at all", "measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "14"}]}, {"title": "Slightly", "measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "6"}]}, {"title": "Moderately", "measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "7"}]}, {"title": "Quite", "measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "5"}]}, {"title": "Extremely", "measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "4"}]}]}]}, {"type": "SECONDARY", "title": "Satisfaction With Diet as Assessed by a 5-point Likert Scale", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"title": "Not at all", "measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}]}, {"title": "Slightly", "measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "7"}]}, {"title": "Moderately", "measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "8"}]}, {"title": "Quite", "measurements": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "11"}]}, {"title": "Extremely", "measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "4"}]}]}]}, {"type": "SECONDARY", "title": "Satisfaction With Exercise as Assessed by a 5-point Likert Scale", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"title": "Not at all", "measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}]}, {"title": "Slightly", "measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "6"}]}, {"title": "Moderately", "measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}, {"title": "Quite", "measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "6"}]}, {"title": "Extremely", "measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "4"}]}]}]}, {"type": "SECONDARY", "title": "Satisfaction With Medication as Assessed by a 5-point Likert Scale", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 weeks postpartum", "groups": [{"id": "OG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks."}, {"id": "OG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"title": "Not at all", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "5"}]}, {"title": "Slightly", "measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "4"}]}, {"title": "Moderately", "measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "7"}]}, {"title": "Quite", "measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "11"}]}, {"title": "Extremely", "measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "9"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "3 weeks postpartum", "eventGroups": [{"id": "EG000", "title": "Placebo", "description": "Compounded placebo\n\nPlacebo: Subjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks.", "seriousNumAffected": 0, "seriousNumAtRisk": 56, "otherNumAffected": 7, "otherNumAtRisk": 56}, {"id": "EG001", "title": "Metformin", "description": "Compounded metformin as the intervention\n\nMetformin: Subjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks", "seriousNumAffected": 0, "seriousNumAtRisk": 46, "otherNumAffected": 12, "otherNumAtRisk": 46}], "otherEvents": [{"term": "Nausea", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 56}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 46}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 56}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 46}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 56}, {"groupId": "EG001", "numEvents": 8, "numAffected": 8, "numAtRisk": 46}]}, {"term": "Hypoglycemia", "organSystem": "Metabolism and nutrition disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 56}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 46}]}, {"term": "Medication Intolerance", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 56}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 46}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr Jerrie Refuerzo", "organization": "University of Texas Health Science Center at Houston", "email": "Jerrie.S.Refuerzo@uth.tmc.edu", "phone": "713.500.7780"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000016640", "term": "Diabetes, Gestational"}], "ancestors": [{"id": "D000011248", "term": "Pregnancy Complications"}, {"id": "D000005261", "term": "Female Urogenital Diseases and Pregnancy Complications"}, {"id": "D000091642", "term": "Urogenital Diseases"}, {"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "relevance": "LOW"}, {"id": "M5114", "name": "Body Weight", "relevance": "LOW"}, {"id": "M19012", "name": "Diabetes, Gestational", "asFound": "Diabetes, Gestational", "relevance": "HIGH"}, {"id": "M14127", "name": "Pregnancy Complications", "relevance": "LOW"}, {"id": "M2875", "name": "Urogenital Diseases", "relevance": "LOW"}, {"id": "M27093", "name": "Female Urogenital Diseases", "relevance": "LOW"}, {"id": "M8399", "name": "Female Urogenital Diseases and Pregnancy Complications", "relevance": "LOW"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "BXS", "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}